SCHEMBL5041560

SCHEMBL5041560

Oc1oc2nc[nH]c2c1Cl

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.37
MEN1 O00255 1/20 0.32
CSNK2A2 P19784 1/20 0.32
RAB9A P51151 1/20 0.32
CSNK2B P67870 1/20 0.32
KMT2A Q03164 1/20 0.32
DYRK1A Q13627 1/20 0.32
CSNK2A3 Q8NEV1 1/20 0.32
DPP4 P27487 1/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039511 0.61 TNF (0.34) KMT2ADYRK1A
SCHEMBL5039485 0.60 CSNK2A1 (0.37) CSNK2A1CSNK2A2DPP4ALDH1A1
SCHEMBL5041323 0.60
SCHEMBL8310415 0.60 GDA (0.46) ALDH1A1
SCHEMBL31290740 0.59 KDM4E (0.47) CSNK2A1MEN1KMT2ADYRK1AALDH1A1
SCHEMBL11362326 0.58 CSNK2A1 (0.54) CSNK2A1MEN1CSNK2A2RAB9ACSNK2B
SCHEMBL5041288 0.58 KDM4E (0.30)
SCHEMBL9829811 0.58
SCHEMBL5495479 0.57
SCHEMBL15068258 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1715840-B1 KERATIN DYEING COMPOSITIONS CONTAINING BICYCLIC FUSED 5-5 HETEROAROMATIC DYES PROCTER & GAMBLE (US) 2008-12-03 EP claimed
EP-1715840-B1 KERATIN DYEING COMPOSITIONS CONTAINING BICYCLIC FUSED 5-5 HETEROAROMATIC DYES PROCTER & GAMBLE (US) 2008-12-03 EP disclosed
US-7303590-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-04 US disclosed
EP-1715840-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-11-02 EP disclosed
EP-1702017-A2 LOW VISCOSITY, HOT-MELT STABLE ADHESIVE COMPOSITIONS KRATON Polymers Research B.V. (NL) 2006-09-20 EP disclosed
US-20050193502-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER, GAMBLE COMPANY, THE 2005-09-08 US disclosed
WO-2005077324-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-25 WO disclosed
WO-2005063914-A2 LOW VISCOSITY, HOT-MELT STABLE ADHESIVE COMPOSITIONS KRATON POLYMERS RESEARCH B.V. (NL) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050193502-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KLK5, CKMT1A; CKMT1B CSNK2A1 861/4885MEN1 4806/4885CSNK2A2 784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.